3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Risk Factor Assessment for Acute Pulmonary Hypertension CrisisPathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, disease, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorderRecruitingNot stated2026-06-22NCT07653958
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid TumorsAdvanced Cancer; Advanced Solid TumorsRecruitingPhase 1 / Phase 22026-05-22NCT06656390
A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLCResectable Non-small Cell Lung CancerNot yet recruitingPhase 22025-06-26NCT07038460